Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

14.19
Delayed Data
As of 4:00pm ET
 -0.74 / -4.96%
Today’s Change
10.80
Today|||52-Week Range
46.33
-5.96%
Year-to-Date

Today’s Trading

Previous close14.93
Today’s open14.79
Day’s range14.16 - 14.99
Volume396,653
Average volume (3 months)938,857
Market cap$646.0M
Dividend yield--
Data as of 4:00pm ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)-171.96%
Earnings growth (this year)+3.18%
Earnings growth (next 5 years)--
Revenue growth (last year)-84.17%
P/E ratioNM
Price/Sales21,235.50
Price/Book1.35

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...-0.52-1.53%
CLLSCellectis SA-0.46-2.51%
CLCDCoLucid Pharmaceutic...+0.60+1.75%
KERXKeryx Biopharmaceuti...-0.24-3.83%
Data as of 4:00pm ET, 01/17/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.77
Annual revenue (last year)$91.4K
Annual profit (last year)-$104.8M
Net profit margin-114,698.50%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts


Search for Jobs